Zacks Research Has Negative Outlook for UNH Q2 Earnings

UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Stock analysts at Zacks Research decreased their Q2 2025 earnings per share estimates for shares of UnitedHealth Group in a research note issued to investors on Thursday, May 1st. Zacks Research analyst D. Chatterjee now expects that the healthcare conglomerate will post earnings per share of $5.93 for the quarter, down from their prior forecast of $7.49. The consensus estimate for UnitedHealth Group's current full-year earnings is $29.54 per share. Zacks Research also issued estimates for UnitedHealth Group's Q3 2025 earnings at $6.66 EPS, Q4 2025 earnings at $6.28 EPS, FY2025 earnings at $26.07 EPS, Q1 2026 earnings at $6.49 EPS, Q2 2026 earnings at $6.12 EPS, Q3 2026 earnings at $7.51 EPS, FY2026 earnings at $29.45 EPS, Q1 2027 earnings at $7.49 EPS and FY2027 earnings at $33.28 EPS.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the previous year, the company earned $6.91 EPS.

Several other research analysts have also weighed in on the stock. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial lowered their price target on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a report on Monday, April 21st. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Finally, Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Four analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $596.86.

UnitedHealth Group Stock Up 1.2 %

Shares of UNH traded up $4.89 during trading on Monday, reaching $404.81. The company's stock had a trading volume of 8,146,436 shares, compared to its average volume of 4,625,259. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a fifty day moving average of $495.85 and a two-hundred day moving average of $528.18. The company has a market cap of $368.47 billion, a price-to-earnings ratio of 26.12, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group has a twelve month low of $393.11 and a twelve month high of $630.73.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 2.08%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. NewSquare Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the 4th quarter worth $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $28,000. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the 4th quarter worth about $30,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.